Kaoru Abiko

15PUBLICATIONS
89CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|Jun 24, 2026
Placental Site Trophoblastic Tumor Acquires Immune Functions by Incorporating Host Maternal Genes.

|Apr 14, 2025
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study.

Yukio Yamanishi, Yasushi Kotani, Aki Kido

|Jul 03, 2024
YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma.

Yoko Furutake, Ken Yamaguchi, Koji Yamanoi

|Sep 17, 2023
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.

Hidehiko Akashi, Nozomi Yachida, Haruka Ueda

|Sep 06, 2022
Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer".

Kaoru Abiko, Junzo Hamanishi, Noriomi Matsumura

Pageof 3

Frequent Collaborators

7 joint publications

Tsukasa Baba

6 joint publications

Junzo Hamanishi

5 joint publications

Noriomi Matsumura

4 joint publications

Ken Yamaguchi